An endogenous serotonergic rhythm acting on 5-HT(2A) receptors may be involved in the diurnal changes in tuberoinfundibular dopaminergic neuronal activity and prolactin secretion in female rats

Neuroendocrinology

Volumn 72, Issue 1, 2000, Pages 11-19

  Liang, Shu Ling ^a   Pan, Jenn Tser ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

5,7 Dihydroxytryptamine; Circadian rhythms; Gonadal steroids; Ketanserin; Prolactin; Serotonin receptors; Tuberoinfundibular dopaminergic neuron

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; 5,7 DIHYDROXYTRYPTAMINE; DOPAMINE; ESTRADIOL; KETANSERIN; PROLACTIN; SEROTONIN; SEROTONIN 2 AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOSE RESPONSE; FEMALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; SEROTONINERGIC SYSTEM;

EID: 0033847970     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054566     Document Type: Article

References (36)

1. Weiner RI, Ganong WF: Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 1978;58:905-976.
2. Tuomisto J, Mannisto P: Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 1985;37:249-332.
3. Pan JT: Neuroendocrine control of prolactin secretion: The role of the serotonergic system. Chin J Physiol 1991;34:45-64.
4. Pan JT, Gala RR: The influence of raphe lesions, p-chlorophenylalanine, and ketanserin on the estrogen-induced afternoon prolactin surge. Endocrinology 1987;120:2070-2077.
5. 1-adrenergic receptor system, is involved in the estrogen-induced afternoon prolactin surge in the rat. Life Sci 1988;42:1869-1874.
6. Clemes JA, Rough ME, Fuller RW: Evidence that serotonin neurons stimulate secretion of prolactin releasing factor. Life Sci 1978;22: 2209-2214.
7. Garthwaite TL, Hagen TC: Evidence that serotonin stimulates a prolactin-releasing factor in the rat. Neuroendocrinology 1979;29:215-220.
8. Pilotte NS, Porter JC: Dopamine in hypophysial portal plasma and prolactin in systemic plasma of rats treated with 5-hydroxytryptamine. Endocrinology 1981;108:2137-2141.
9. Chen YF, Ramirez VD: Serotonin stimulates thyrotropin-releasing hormone release from superfused rat hypothalami. Endocrinology 1981; 108:2359-2366.
10. Ohta H, Kata Y, Shimatsu A, Tojo K, Kabayama Y, Inou T, Yanaihara N, Imura H: Inhibition by antiserum to vasoactive intestinal polypeptide (VIP) of prolactin secretion induced by serotonin in the rat. Eur J Pharmacol 1985;109: 409-412.
11. Lynch CO, Johnson MD, Crowley WR: Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: Evidence for serotonin-catecholamine interactions. Life Sci 1984;35:1481-1487.
12. Mathiasen JR, Tomogane H, Voogt JL: Serotonin-induced decrease in hypothalamic tyrosine hydroxylase activity and corresponding increase in prolactin release are abolished at mid-pregnancy and transplants of rat choriocarcinoma cells. Endocrinology 1992;131:2527-2532.
13. Bosler O, Joh TH, Beaudet A: Ultrastructure relationships between serotonin and dopamine neurons in the rat arcuate nucleus and medial zona incerta: A combined radiographic and immunocytochemical study. Neurosci Lett 1984; 48:279-285.
14. Kiss J, Halasz B: Synaptic connections between serotonergic axon terminals and tyrosine hydroxylase-immunoreactive neurons in the arcuate nucleus of the rat hypothalamus. A combination of electron microscopic autoradiography and immunocytochemistry. Brain Res 1986;364:284-294.
15. Mai LM, Shieh KR, Pan JT: Circadian changes of serum prolactin levels and tuberoinfundibular dopaminergic neuron activities in ovariectomized rats treated with or without estrogen: The role of the suprachiasmatic nuclei. Neuroendocrinology 1994;60:520-526.
16. Shieh KR, Pan JT: Sexual differences in the diurnal changes of tuberoinfundibular dopaminergic neuron activity in the rat: Role of cholinergic control. Biol Reprod 1996;54:987-992.
17. Mornex R, Jordan D: Serotonin and endocrine rhythms. Biomedicine 1980;32:163-165.
18. Kordon C, Hery M, Szafarszyk A, Ixart G, Assenmacher I: Serotonin and the regulation of pituitary hormone secretion and of neuroendocrine rhythms. J Physiol (Paris) 1981;77:489-496.
19. Reader TA: Neurotoxins that affect central indolcamine neurons; in Boulton AA, Baker GB, Juorio AV (eds): Neuromethods: Drugs as Tools in Neurotransmitter Research. Clifton, Humana. 1989, vol 12, pp 49-102.
20. 2 receptor blockade to study serotonin-induced pathology. Trends Pharmacol Sci 1983;4:198-207.
21. Goodman RL: A quantitative analysis of the physiological role of estradiol and progesterone in the control of tonic and surge secretion of luteinizing hormone in the rat. Endocrinology 1978;102:142-150.
22. Lin JY, Mai LM, Pan JT: Effects of systemic administration of 6-hydroxydopamine, 6-hydroxydopa and 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) on tuberoinfundibular dopaminergic neurons in the rat. Brain Res 1993;624:126-130.
23. Banky Z, Molnar J, Csernus V, Halasz, B: Further studies on circadian hormone rhythms after local pharmacological destruction of the serotonergic innervation of the rat suprachiasmatic region before the onset of the corticosterone rhythm. Brain Res 1988;445:222-227.
24. Hery M, Laplante E, Kordon C: Participation in the phasic release of luteinizing hormone. II. Effects of lesions of seroton in-containing pathways in the central nervous system. Endocrinology 1978;102:1019-1025.
25. Markou A, Kosten TR, Koob GF: Neurobiological similarities in depression and drug dependence: A self-medication hypothesis. Neuropsychopharmacology 1998;18:135-174.
26. Kahn RS, Davidson M: Serotonin, dopamine and their interactions in schizophrenia. Psychopharmacology 1993;112:S1-S4.
27. Korczyn AD: Parkinson's disease; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 1479-1484.
28. Pan JT: Neuroendocrine function of dopamine; in Stone TW (ed): CNS Neurotransmitters and Neuromodulators: Dopamine. Boca Raton, CRC Press, 1996, pp 213-232.
29. Kapur S, Remington G: Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996;153:466-476.
30. Benloucif S, Galloway MP: Facilitation of dopamine release by serotonin agonists: Studies with microdialysis. Eur J Pharmacol 1995;119: 179-185.
31. Parsons LH, Justice JB: Perfusate serotonin increases extracellular dopamine in the nucleus accumbens of the rat as measured by in vivo microdialysis. Brain Res 1993;606:195-199.
32. Yang ICH, Pan JT: Effects of serotonin depletion by p-chlorophenylalanine, p-chloroamphetamine or 5,7-dihydroxytryptamine on central dopaminergic neurons: Focus on tuberoinfundibular dopaminergic neurons and serum prolactin. J Biomed Sci 1999;6:183-193.
33. Pan JT, Tai MH: Effects of ketanserin on DOI, mCPP and TRH-induecd prolactin secretion in estrogen-treated rats. Life Sci 1992;51:839-845.
34. Cohen IR, Wise PM: Effects of estradiol on the diurnal rhythm of serotonin activity in microdissected brain area of ovariectomized rats. Endocrinology 1988;122:2619-2625.
35. Roth RH, Murrin LC, Walters JR: Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur J Pharmacol 1976;36: 163-171.
36. Lookingland KJ, Jarry HD, Moore KE: The metabolism of dopamine in the median eminence reflects the activity of tuberoinfundibular neurons. Brain Res 1987;419:303-310.